Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Hematology"
DOI: 10.1007/s12185-020-02989-5
Abstract: We have read with great interest the paper of Izutsu et al., referring to the data of the AUGMENT phase III clinical trial that report the benefit of lenalidomide plus rituximab (R-Len) for relapsed refractory… read more here.
Keywords: relapsed refractory; six cycles; complete metabolic; metabolic remission ... See more keywords